Hurry - Only 2 left in stock!
|
Chapter 1: Technology and Physics of SPECT/CT
Chapte 2: Use of SPECT/CT for dosimetry
Chapte 3: SPECT/CT for parathyroid and thyroid imaging
Chapte 4: SPECT/CT for thyroid cancer imaging
Chapte 5: 123Iod-MIBG SPECT/CT for tumor imagingChapte 6: SPECT/CT for neuroendocrine tumors
Chapte 7: Bone SPECT/CT in oncology
Chapte 8: Bone SPECT/CT in orthopaedicsChapte 9: SPECT/CT for cardiac scintigraphy
Chapte 10: SPECT/CT in sentinel node scintigraphy
Chapte 11: Lung SPECT/CT
Chapte 12: Therapy planning in selective internal radiation therapy of liver tumors with SPECT/CT
Chapte 13: Bremsstrahlung SPECT/CT
Chapte 14: Miscellaneous (Brain SPECT/CT, inflammation, radiation planning, GI-Tract)
Prof. Dr. Hojjat Ahmadzadehfar, MSc is head of the
Department of Nuclear Medicine at the Klinikum Westfalen in
Dortmund, Germany. He received his medical degree from Guilan
Medical University, Iran (1999) and completed his residency in
Nuclear Medicine in Germany at the Department of Nuclear Medicine,
University Hospital Bonn, Germany (2003-2008). From 2008 to 2013 he
was the assistant medical director at the Department of Nuclear
Medicine, University Hospital Bonn, and from 2013 until the end of
2019 he served as the head of the therapy section of the Department
of Nuclear Medicine, University Hospital Bonn. Prof. Ahmadzadehfar
serves as an editor and reviewer for several international journals
and has authored and co-authored over 180 papers and book chapters.
His main research areas are targeted radionuclide therapy and
theranostics.
Prof. Dr. Hans-Jürgen Biersack was a Professor of Nuclear Medicine at the University of Bonn for more than 30 years and is now an Emeritus Professor. He has many years of experience as Director of the Klinik und Poliklinik für Nuklearmedizin in Bonn. In the course of a long and distinguished career, he has served as President of both the German Society of Nuclear Medicine (1992–1994) and the World Federation of Nuclear Medicine and Biology (1994–1998). He has received a number of awards, including the Georg von Hevesy Medal (2000), and was a Badgastein Lecturer in 1988, Dr. Luis Guerrero Lecturer in 1994, and L. Rao and Shanta Chervu Lecturer in 2000. He holds the Order of Merit from the Federal Republic of Germany and the Sign of Honor from the Red Cross. Professor Biersack has served on the editorial boards of numerous leading journals, and as editor for several journals. He is the author of 440 papers cited in PubMed/MEDLINE as well as 310 book chapters and 35 books. He continues to work at the Betaclinic Bonn.
Prof. Dr. Ken Herrmann graduated from Charité
Universitätsmedizin in Berlin, Germany in 2004 including stays at
the Universite de Lausanne, Universidad Austral de Chile in
Valdivia, and Memorial Sloan-Kettering Cancer Center in New
York. Dr. Herrmann was trained in nuclear medicine at the
Technische Universität München under the guidance of Professor
Markus Schwaiger and subsequently completed an executive MBA at the
University of Zürich. From 2011 to 2021, he has been a
faculty member at the Department of Molecular and Medical
Pharmacology of the University of California, Los Angeles
(UCLA). In addition, from 2012 to 2016 Dr. Herrmann
served as Vice Chair of Nuclear Medicine at the
Universitätsklinikum Würzburg. In 2016 he was appointed Chair of
Nuclear Medicine at the Universitätsklinikum Essen, Germany. Dr.
Herrmann’s research focuses on hybrid molecular imaging including
SPECT/CT and PET/CT and its clinical applications, on radionuclide
theranostics, and on SPECT-/PET-based response assessment to
oncologic therapies.
![]() |
Ask a Question About this Product More... |
![]() |